文源 | 源媒汇作者 | 胡青木编辑 | 苏淮“并购狂人”华润医药,开始卖资产了。过去几年,华润医药在医药领域的并购动作频繁且精准,不断拓展和深化其在行业的布局。2022年末,华润三九入主昆药集团,随后通过整合资源,解决了双方在血塞通软胶囊产品上的同业竞争问题,进一步巩固了昆药集团在心脑血管领域的优势;2024年,华润三九又成为天士力的控股股东,这一举措不仅为华润医药带来了复方丹参滴丸等心脑血管...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.